Intraosseous infusion devices are used for the administration of fluids, medications and blood products in emergency situations where intravenous access is difficult or impossible. These devices provide direct access to the venous system by puncturing the marrow cavity in the bone such as tibia or humerus. They are useful in pediatric and adult emergency medical conditions where vascular access cannot be established. Intraosseous access allows for faster delivery of emergency drugs and fluids when compared to intravenous access. It is being widely adopted for the management of trauma, cardiac arrest, and prehospital emergencies.
The global intraosseous infusion devices market is estimated to be valued at US$ 1111.7 Mn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 to 2031.
Key Takeaways
Key players: Key players operating in the intraosseous infusion devices market are PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., BIOPSYBELL S.R.L., Becton Dickinson Company, Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc.
Key opportunities: Increasing incidence of trauma injuries and cardiovascular emergencies along with growth in disposable income in developing nations present significant growth opportunities for players in this market over the forecast period.
Global expansion: Major players are focusing on geographical expansion plans through collaborations and partnerships to strengthen their presence across international markets particularly in Asia Pacific and Latin America.
Market drivers:
The rapidly Intraosseous Infusion Devices Market Growth preference for emergency medical care along with rising for easy-to-use and portable are some of the major factors expected to drive the growth of this market over the forecast period. Growing adoption of IO access in military medicine will further propel the market growth.
PEST Analysis
Political: Intraosseous infusion devices are classified as class II medical devices by the U.S. Food and Drug Administration (FDA). New devices have to undergo stringent approval process from regulatory bodies like FDA to be marketed and sold.
Economic: As healthcare expenditure is on rise globally driven mainly by aging population and increasing income levels, demand for devices that enable quick access to veins in emergency situations is accelerating. Disposable devices see higher adoption against reusable ones due to safety and cost advantages.
Social: With increasing acceptance of advanced medical technologies for life support in pre-hospital emergency care settings, IO infusion devices are emerging as an effective alternative to intravenous therapy in patients with difficult venous access. Wider social awareness about critical care also boosts their adoption.
Technological: Major players are focusing on developing easy to use, compact and battery operated devices to facilitate faster fluid administration during medical emergencies. Some innovators are exploring Bone Conduction Technology to enable hands-free communication for first responders using these devices.
The intraosseous infusion devices market in terms of value is concentrated majorly in North America and Europe. North America alone accounts for over 40% share driven by growing adoption of advanced life support systems in EMS. Existence of advanced healthcare infrastructure and high healthcare spending have propelled the market in these regions.
Asia Pacific is identified as the fastest growing regional market for intraosseous infusion devices propelled by increasing healthcare investments, rising awareness about critical care and growing patient population. China, India and other Association of Southeast Asian Nations (ASEAN) countries offer lucrative growth opportunities for players due to improving access to modern medical technologies. Expanding medical tourismindustry further augurs well for market prospects in Asia Pacific.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author – Vaagisha Singh
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups. LinkedIn